S-1/A: United Health Products Files Amendment No. 3 to Form S-1 Registration Statement
S-1/A Filing
United Health Products, Inc. files an amendment to its S-1 registration statement to include a new exhibit related to accounting firm consent.
Summary
- United Health Products, Inc. filed Amendment No. 3 to its Registration Statement on Form S-1 to include a new Exhibit 23.1.
- The amendment primarily concerns the filing of a new consent from MAC Accounting Group, LLP.
- The original prospectus and the balance of the Registration Statement remain unchanged.
- The document details other expenses of issuance and distribution, estimated at $23,338.74.
- It also covers indemnification of directors and officers as permitted by Nevada law.
- The document summarizes recent sales of unregistered securities since January 1, 2021, including numerous transactions with White Lion Capital LLC.
- The filing includes a list of exhibits, including articles of incorporation, bylaws, service agreements, and stock purchase agreements.
- The document also outlines undertakings related to filing post-effective amendments and addressing potential liabilities under the Securities Act of 1933.
Sentiment
Score: 4
Explanation: The document is primarily a regulatory filing, so the sentiment is neutral. However, the extensive history of unregistered stock sales and reliance on a single investor raise concerns, leading to a slightly negative sentiment.
Positives
- The company is taking steps to comply with SEC regulations by filing necessary amendments to its registration statement.
- The inclusion of the accounting firm's consent is a standard part of the registration process.
- The company is addressing its legal and financial obligations, including settling litigation and disgorgement obligations.
Negatives
- The company has engaged in numerous unregistered sales of common stock, which may raise regulatory scrutiny.
- The company has issued a significant number of shares to settle debts and compensate consultants, potentially diluting existing shareholders.
- The company has a history of litigation and settlements, which could indicate underlying business or compliance issues.
Risks
- The company's reliance on unregistered stock sales to raise capital could pose regulatory risks.
- The continued issuance of shares for debt settlement and compensation may dilute shareholder value.
- The company's history of litigation could lead to future legal challenges and financial burdens.
- The company's ability to maintain compliance with securities laws is crucial for its future operations.
Future Outlook
The registration statement will become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
Industry Context
This filing is a standard part of the process for companies seeking to raise capital through the public markets. The details regarding unregistered securities sales and related party transactions are important for investors to assess the company's financial practices and potential risks.
Comparison to Industry Standards
- The level of detail provided regarding unregistered securities sales is more extensive than what is typically seen in registration statements, suggesting a higher level of scrutiny may be warranted.
- The company's reliance on a single entity, White Lion Capital LLC, for a significant portion of its financing is unusual and could be compared to similar arrangements in other small-cap companies.
- The indemnification provisions for directors and officers are standard practice, but the specific language should be compared to those of other Nevada-incorporated companies.
Related Party Transactions
- The document details numerous transactions with White Lion Capital LLC, which should be carefully reviewed to assess potential related party issues.
- The issuance of shares to officers, consultants, and legal counsel in satisfaction of debt and accrued liabilities also constitutes related party transactions.
Stakeholder Impact
- Existing shareholders may experience dilution due to the issuance of new shares.
- The company's ability to raise capital will impact its future operations and growth potential.
- The company's compliance with securities laws will affect its reputation and investor confidence.
Next Steps
- The registration statement needs to be declared effective by the SEC.
- The company will then be able to offer and sell the registered securities.
- The company will need to file post-effective amendments as required by the Securities Act of 1933.
Key Dates
| Date | Description |
|---|---|
| February 28, 1997 | Date of Articles of Incorporation of the Company |
| January 1, 2021 | Start date for summary of transactions involving unregistered issuance and redemption of common equity securities |
| January 11, 2021 | Incorporation by reference to the Form 8-K dated January 11, 2021 |
| June 23, 2022 | Incorporation by reference to the Form 8-K dated June 23, 2022 |
| September 1, 2022 | Stock Purchase Agreement date between the Company and White Lion Capital LLC |
| January 25, 2023 | Amendment to Stock Purchase Agreement date |
| December 31, 2023 | Date of financial statements for which MAC Accounting Group, LLP provided consent |
| April 1, 2024 | Date of report from MAC Accounting Group, LLP relating to the financial statements of United Health Products, Inc. for the year ended December 31, 2023 |
| June 20, 2024 | Second Amendment to Stock Purchase Agreement date |
| June 25, 2024 | Incorporation by reference to the Form 8-K dated June 25, 2024 |
| July 22, 2024 | Date of consent from Mac Accounting Group & CPAs, LLP |
| July 25, 2024 | Date of the Registration Statement on Form S-1 |
Keywords
S-1/A, registration statement, securities, common stock, unregistered securities, White Lion Capital, MAC Accounting Group, indemnification, Nevada, United Health Products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.